MyTomorrows

MyTomorrows' platform serves users in 17 countries, allowing doctors and patients to access drugs still in development. At the same time, pharmaceutical companies can use this one-stop platform to better conduct early global sales of their drugs. The primary goal is to enable patients suffering from terminal and debilitating diseases to try new medications, collect crucial data, and help bring these drugs to market more quickly.